Voyageur Pharmaceuticals CEO Brent Willis joins Natalie Stoberman from the Proactive studio to share the launch of its latest product SmoothX.
Willis says SmoothX is intended for use in computed tomography (CT) of the abdomen and pelvis to delineate the gastrointestinal (GI) tract in adult and pediatric patients.